Please login to the form below

Not currently logged in
Email:
Password:

NHS news in brief

Our weekly round of NHS and healthcare stories

Wrong drugs given in many care homes, says report
Nearly fifty per cent of nursing and care homes in England are failing to meet the minimum drug prescribing standards, according to the Commission for Social Care Inspection. In a report on 19,500 homes, the body said it found many cases of patients being given the wrong medication, drugs in the wrong dose or no medication at all. ìGiving people the right medicine, in the right dose, at the right time is critical,î said Commission chairman Dame Denise Platt. ìIt is vital that all care homes treat this issue with the utmost seriousness. They have a duty of care towards the people in their homes.î

Crack MRSA teams to help NHS trusts
So-called 'hit squads' are to descend on the 20 NHS trusts with the worst record on fighting the superbug MRSA, the Department of Health has announced. Around one half of trusts in England are said to be making poor progress towards a target to cut MRSA infections by 50 per cent by 2008. ìThese teams will begin first-wave work at Sandwell, Northumbria and Aintree NHS trusts who have volunteered for help, and then move on to around 17 more trusts through 2006,î said health minister Jane Kennedy. The teams will have to diagnose what is preventing hospitals from reducing the number of MRSA cases and formulate practical action plans.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics